A nurse is preparing to administer the MMR (measles, mumps, rubella) vaccine to a 15-month-old child. Upon retrieving the vaccine from storage, the nurse notices that the refrigerator temperature log shows the unit was at 45°F (7.2°C) for 8 hours overnight due to a power outage. What is the most appropriate nursing action?

When a temperature excursion is identified, such as an MMR vaccine stored at 45°F (7.2°C) for 8 hours, immediate action is required to prevent administration of a potentially non-viable vaccine. The MMR vaccine is a lyophilized, live attenuated vaccine that must remain frozen during storage; exposure to temperatures above the recommended range can lead to irreversible loss of potency.

Immediate Steps:

1. Quarantine the Vaccine: Clearly label the affected vials "DO NOT USE" and store them separately from other viable vaccines, still under proper refrigeration, until a determination is made.
2. Do Not Administer: The vaccine must not be given to any patient. The 8-hour exposure invalidates the manufacturer's guarantee of potency.
3. Contact Manufacturer or Health Department: The manufacturer's stability data is the only reliable source to determine if the vaccine is still viable. Local or state health departments can also provide guidance on reporting and replacement.
4. Document the Event: Record the date, time, duration of the excursion, maximum temperature reached, and actions taken on the temperature log and an incident report.

Key Safety Principles:

• Never refreeze a thawed live vaccine; this does not restore its original potency and can introduce contamination risks.
• Vaccine appearance is not a reliable indicator of potency; a thawed and refrozen vaccine may look identical to a viable one.
• Always follow the manufacturer's package insert for specific storage and excursion handling instructions.